GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 80 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $155 | +21.1% | 40 | 0.0% | 0.00% | – |
| Q2 2021 | $128 | +47.1% | 40 | 0.0% | 0.00% | – |
| Q1 2021 | $87 | -3.3% | 40 | 0.0% | 0.00% | – |
| Q4 2020 | $90 | -15.9% | 40 | 0.0% | 0.00% | – |
| Q3 2020 | $107 | -12.3% | 40 | 0.0% | 0.00% | – |
| Q2 2020 | $122 | +56.4% | 40 | 0.0% | 0.00% | – |
| Q1 2020 | $78 | -31.6% | 40 | 0.0% | 0.00% | – |
| Q4 2019 | $114 | -22.4% | 40 | 0.0% | 0.00% | – |
| Q3 2019 | $147 | -11.4% | 40 | 0.0% | 0.00% | – |
| Q2 2019 | $166 | -18.6% | 40 | 0.0% | 0.00% | – |
| Q1 2019 | $204 | +48.9% | 40 | 0.0% | 0.00% | – |
| Q4 2018 | $137 | -42.9% | 40 | 0.0% | 0.00% | – |
| Q3 2018 | $240 | -5.5% | 40 | 0.0% | 0.00% | – |
| Q2 2018 | $254 | +33.7% | 40 | 0.0% | 0.00% | – |
| Q1 2018 | $190 | +41.8% | 40 | 0.0% | 0.00% | – |
| Q4 2017 | $134 | +55.8% | 40 | 0.0% | 0.00% | – |
| Q3 2017 | $86 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 184,742 | $401,000 | 0.10% |
| Geneos Wealth Management Inc. | 511,606 | $2,261,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $26,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,967 | $41,000 | 0.01% |
| Vivaldi Capital Management LP | 10,668 | $45,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,221,984 | $2,651,000 | 0.01% |
| CENTAURUS FINANCIAL, INC. | 15,614 | $34,000 | 0.00% |
| WEDBUSH SECURITIES INC | 17,998 | $39,000 | 0.00% |
| D.A. DAVIDSON & CO. | 65,310 | $142,000 | 0.00% |
| Virtu Financial LLC | 14,683 | $32,000 | 0.00% |